morgan_blumberg-083022.png

Morgan spent five years in investment banking at Morgan Stanley. She worked on a presidential campaign, at Bloomberg Philanthropies and consulted for start-ups in the political media space.

IMG_0264_edit-color corrected.png

As M13's community program coordinator, Samantha aligns with M13’s commitment to creating an inclusive community through authentic experience, dedication to innovation, and creativity. Samantha was previously the development associate for outreach and programming at Rockefeller University.

Samantha Hughes

Operator

As M13's community program coordinator, Samantha aligns with M13’s commitment to creating an inclusive community.

M13SharePeople-SEO image Samantha Hughes

Samantha Hughes | M13

Generra-headshot_0134_MASKED.png

As M13's brand project specialist, Generra brings her experience in operational excellence and community building from her previous time at The Knowledge House, a tech non-profit. Prior to that, Generra led project management, from enrollment and ops to data management, for Newark Public Schools. 

Generra Rodriguez

As M13's brand project specialist, Generra brings her experience in operational excellence and community building from her previous time at The Knowledge House, a tech non-profit. 

M13SharePeople-SEO image Generra Rodriguez

Generra Rodriguez | M13

Lizzie_DMF0400_final_masked_forwebsite.png

As a partner and head of operations, Lizzie leads the Propulsion team that helps propel our founders’ businesses forward. She was previously the COO of sneaker marketplace GOAT Group, CMO of Gilt Groupe, and founding partner of Brilliant Ventures.

Lizzie Francis

Partner

As a partner and head of operations, Lizzie leads the Propulsion team that helps propel our founders’ businesses forward. She was previously the COO of sneaker marketplace GOAT...

M13SharePeople-LizzieFrancis

Lizzie Francis | M13

Erik_IMG_0036_masked.png

Erik is M13's accountant and has a vast background working in tech companies and the applications used in accordance with GAAP for reporting. Erik was previously an accountant at Glamsquad and Stella Connect, which was acquired by NYSE listed Medallia in 2020, which gave Erik the opportunity to oversee the finance integrations of the two companies. 

Erik Grant

Erik is M13's accountant and has a vast background working in tech companies and the applications used in accordance with GAAP for reporting.

M13SharePeople-SEO image Erik Grant

Erik Grant | M13

Feven-67_trans_800.png

Feven was an investment analyst for KingsCrowd while simultaneously receiving a certificate from Cornell’s Women and Entrepreneurship program, where she focused on the start-up ecosystem for minority groups.

Feven Solomon

Investor

Feven was an investment analyst for KingsCrowd while simultaneously receiving a certificate from Cornell’s Women and Entrepreneurship program, where she focused on the start-up...

M13SharePeople-FevenSolomon

Feven Solomon | M13

talitha_wright-083022.png

As a member of the investor relations team, Talitha has worked with the team to build the IR systems at M13 from the ground up. She was previously the quality control and administrative assistant for the accounting and assurance department of Lindsay & Brownell, LLP.

Talitha Wright

As a member of the investor relations team, Talitha has worked with the team to build the IR systems at M13 from the ground up. She was previously the quality control and...

M13SharePeople-TalithiaWright

Talitha Wright | M13

sarah_tomolonius-083022.png

Sarah was previously the VP of marketing and investor relations at Arlon Group and has served in IR roles at StepStone Group and Citi Private Equity. She is a public company board member, co-founded the Sustainability Investment Leadership Council, and has served on numerous non-profit boards.

Sarah Tomolonius

Sarah was previously the VP of marketing and investor relations at Arlon Group and has served in IR roles at StepStone Group and Citi Private Equity. She is a public company...

M13SharePeople-SarahTomolonius

Sarah Tomolonius | M13

rita_serrano-083022.png

A people operations analyst, Rita was previously the owner and operator of Street Beatz Dance Company. Prior to that, she held the roles of internal annuity specialist and registered client associate at Merrill Lynch.

Rita Serrano

A people operations analyst, Rita was previously the owner and operator of Street Beatz Dance Company. Prior to that, she held the roles of internal annuity specialist and...

M13SharePeople-RitaSerrano

Rita Serrano | M13

latif_peracha.png

Latif manages the overall investing strategy for the firm and has led numerous deals across money and health verticals with a large focus on web3. He was previously the managing director at Virgin Group where he led investing in the Americas including investments in Ring (acq. by AMZN), Slack (NYSE: WORK), Virgin Galactic (NYSE: SPCE), and Virgin Orbit (NASDAQ: VORB).

Latif Peracha

As M13’s general partner, Latif manages the investing strategy for the firm and has led numerous deals across money, health, and web3 verticals. He was previously a managing...

M13SharePeople-LatifPeracha

Latif Peracha | M13

IMG_0407_edited_masked.png

As a principal at M13, Karim leads investments across the firm’s future of money and work themes. Karim was a GTM leader at four fintech companies including Remitly (IPO’d in 2021), Carta, CommonBond and Yodlee (IPO’d in 2014). Prior to joining M13, Karim personally invested in Carta, Auth0, GitLab, Chipper Cash, and Doorvest.

Karim Bhalwani

As a principal at M13, Karim leads investments across the firm’s future of money and work themes. Karim was a GTM leader at four fintech companies including Remitly...

M13SharePeople-KarimBhalwani

Karim Bhalwani | M13

Morgan Blumberg

anna_barber.png

A partner at M13, Anna was the managing director of Techstars LA and also a partner in The Fund LA. A certified executive coach, Anna has worked as a corporate lawyer, McKinsey consultant, product exec, and entrepreneur. She serves on the Advisory Board of PledgeLA and is a member of AllRaise.

Anna Barber

A partner at M13, Anna was the managing director of Techstars LA and also a partner in The Fund LA. A certified executive coach, Anna has worked as a corporate lawyer...

M13SharePeople-AnnaBarber

Anna Barber | M13

Morgan spent five years in investment banking at Morgan Stanley. She worked on a presidential campaign, at Bloomberg Philanthropies and consulted for start-ups in the political...

M13SharePeople-MorganBlumberg

Morgan Blumberg | M13

They may be the future’s great hope, the generation driving their Gen X parents crazy, or both. 

header

How Gen Z is Driving the Future of Work, Commerce and Living

Gen Z may be the future’s great hope, the generation driving their Gen X parents crazy, or both.  They are driving innovation in how we work, shop, socialize, and live.

thumbnail

What do Gen Z care about and how are they shaping innovation? | M13

**_This is the latest article that takes a closer look at M13’s Future of Health thesis._** 
Chronic diseases are the leading driver in US healthcare expenditure, making up approximately half of US healthcare spent or 10% of GDP. These conditions are generally ongoing and cause functional restriction, but can oftentimes be prevented. Managing a chronic illness is a lifelong and complex task that includes medication regimes, regular doctor visits, and surgical procedures. This burden of chronic diseases often shatters productive lives with fragmented patient journeys and expensive medical bills. However, we know that this burden can be lessened with early detection, lifestyle changes, medication management, and therapy. Digital health has great potential to deliver these integrated services and greatly improve chronic care management. 
M13 has been investing in and studying digital health specialty solutions. These companies incorporate high-touch continuous interaction and digital care models that have the potential to simultaneously decrease the total cost of care and improve patient outcomes and quality of life. 
In this article, we will share: 
<DotBullet text="An overview of chronic conditions and economic impact" />
<DotBullet text="Market maps featuring companies that are actively addressing key chronic conditions" />
<DotBullet text="What digital care innovation will need to prove to succeed" /> 
## The magnitude of chronic disease and their impact on overall healthcare costs 
Five areas of chronic conditions make up a significant part of the $4.1T annual healthcare spend in the US: musculoskeletal (MSK), heart diseases, neurological conditions, gastrointestinal conditions, and diabetes. This is not an exhaustive list of all chronic care but they are among the most prevalent. Chronic conditions often occur simultaneously, and addressing the underlying causes could have positive implications for multiple diseases. 
The following diagram details the number of Americans struggling with common chronic diseases. We believe there is a potential for digital health solutions to intervene, especially when it comes to protocol adherence and early detection and intervention. The promise of digital health is reducing disease severity and ultimately the number of people impacted by these chronic conditions. 
<center>![Specialty care - chronic conditions diagram](//images.ctfassets.net/vcjxvx0h1a5n/7gbtTIe1jRpGlg9WSX6xbF/7c278636e279b760a09da9d8ad526ef9/specialty_care-blog-graphics_v2_chronic_condition_diagram.png)</center>
<center>_Source: [Chronic Disease in the United States](https://www.americanactionforum.org/research/chronic-disease-in-the-united-states-a-worsening-health-and-economic-crisis/)_</center> 
Another promise of digital health is that its accessible and prevention-focused care models can reduce unnecessary medical costs. While research detailing expenditures by condition varies, we have noted our sources and do not expect that digital health solutions will fully replace the need for all direct medical costs. Direct medical costs—from doctor's visits and medication to hospitalization and surgery—tell only part of the chronic condition story: disability and loss of productivity are some of the indirect costs that drain billions from our health system annually. 
<center>![Healthcare costs by Specialty](//images.ctfassets.net/vcjxvx0h1a5n/34JycfNFYMAv4zV5jreeIM/933fb890758a7da40f7557350acc2ce4/By_Costs_v4.png)</center>
<center>_Sources: [GI Conditions](https://www.jwatch.org/na47723/2018/10/23/burden-and-costs-gastrointestinal-disease-us), [MSK Conditions](https://www.sciencedaily.com/releases/2016/03/160301114116.htm), [Diabetes](https://www.niddk.nih.gov/health-information/health-statistics/diabetes-statistics), [Heart Disease](https://www.heart.org/-/media/Files/Get-Involved/Advocacy/Burden-Report-Consumer-Report.pdf) and [Neurological Conditions](https://jamanetwork.com/journals/jamaneurology/fullarticle/2772579#:~:text=According%20to%20Gooch%20et%20al,more%20than%201000%20neurological%20disorders)_
</center> 
## Market maps: companies and chronic conditions
Below are the five featured chronic conditions and ways that digital care companies are working to achieve better patient outcomes and lower cost of care. 
#### Cardiovascular conditions: shifting acute to preventive care
In most cases, a good cardiologist can achieve great patient outcomes and address hypertension by coaching their patients on lifestyle changes and properly adjusting their medication plan. However, this requires a lot of high-touch interactions and time that many doctors often don’t have. 
Virtual-first care enables these high-touch journeys with more efficiency and greater convenience for patients. They also have the opportunity to improve access to cardiology care and increase rehabilitation completion rates. For example, cardiac rehab is proven to reduce hospital readmissions by 50%, but 90% of patients do not participate in these programs because they lack access or have no convenient option to enroll. 
Virtual cardiac recovery-focused businesses like [Recora](https://www.recora.com/), [Carda Health](https://www.cardahealth.com/), and [Moving Analytics](https://www.movinganalytics.com/) partner with providers to offer everything from live exercise, nutrition, and mindfulness at the touch of a button. Virtual first cardiology providers like [Heartbeat Health](https://www.heartbeathealth.com/), [Gordy Health](https://gordyhealth.com/), and [Ventricle Health](https://www.ventriclehealth.com/) are more focused on prevention and offer full-stack clinical services including in-home diagnostics. 
<center>![Specialty Care - cardiovascular companies chart](//images.ctfassets.net/vcjxvx0h1a5n/5PC3M98AJmVk5ufH6dq235/708d39a9920ce6b90209f90facd7574a/specialty_care-blog-graphics_v2_cardiovascular.png)</center> 
#### Gastrointestinal (GI) conditions: personalizing treatments
GI conditions like Inflammatory Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD) are chronic and will require a lifetime of disease management. There is little known about prevention, so most solutions are focused on offering high-touch and iterative treatment plans. Tracking symptoms and behaviors like diet, sleep, and psychological conditions can help identify personalized triggers. Understanding these triggers can inform treatments that result in reduced symptoms and less frequent, less severe flares. 
In combination with in-person visits, digital care programs and complementary care providers are able to deliver personalized treatments at scale. For example, [Agora Health](https://www.myagorahealth.com/) has developed a clinically validated personalized elimination diet program proven to drive significant remission rates among IBS and IBD patients. Agora works with patients, providers, and care coordination partners to bridge necessary gaps between in-person visits. [Oshi](https://oshihealth.com/) and [Vivante](https://vivantehealth.com/) are partnering with employers to offer diagnosis and care management as an employee benefit. 
<center>![Specialty Care - GI companies chart](//images.ctfassets.net/vcjxvx0h1a5n/34EuSWNhTU3kFtGD7xCtoP/31fe80c93fd84eabee86b084ed085d83/Gi-M13_v3.png)</center>
<center>_Note: There are some companies in the above diagram that are focused on autoimmune disease more broadly compared to IBD / IBS specifically._</center> 
#### Diabetes / pre-diabetes: real-time monitoring and care guidance
Diabetes patients can live a very normal life with proper measures including weight management, lifestyle changes, and the right prescription drugs. If not managed, diabetes can result in severe (and costly) consequences such as eyesight, kidney, and nerve damage; high blood pressure and cholesterol that increases the risk of stroke; and infection and sores that require amputation. 
Continuous monitoring solutions are becoming more pervasive. Monitoring solutions help patients and doctors continuously track how well this condition is managed and whether progress is being made. Companies focused on providing real-time monitoring and care guidance include [Livongo](https://www.livongo.com/), [Perry Health](https://www.perryhealth.com/), [9am](https://9am.health/), etc. Given the financial burden that diabetes places on the employer, companies like [Virta](https://www.virtahealth.com/) and [Ciba Health](https://cibahealth.com/) are taking a holistic, root-cause approach to type 2 diabetes reversal. 
There are also several companies focused on prevention via weight management, nutrition, and care navigation. We are investors in [Form Health](https://www.formhealth.co/), whose approach of acquiring patients through physician referrals is a winning strategy. Form’s team of obesity specialists is able to provide more personalized treatment plans and convenient monitoring than a primary care provider has the capacity to provide. 
When The Centers for Medicare & Medicaid Services (CMS) made remote patient monitoring (RPM) solutions reimbursable, several well-funded companies were built around this regulation. However, their revenue potential will be put at risk if CMS makes adjustments to these reimbursement rates or scraps them altogether if they don't yield the promised outcomes. For companies in this field to prevail, they will need to be extremely ROI driven and show they can improve management of diabetes through better data, patient experience, and digital programs. 
<center>![Specialty Care - Diabetes companies chart](//images.ctfassets.net/vcjxvx0h1a5n/2eDc94fbVeGRr8ZazvpiuQ/61d5b5c6e8ee017964e23fc48163e1fe/Diabetes-M13_v3.png)</center> 
#### Neurological conditions: detecting early and treating preventatively
Neurology includes a range of conditions. Some of these conditions follow a similar pattern as the other chronic conditions discussed so far: early detection and better disease management can greatly impact patient outcomes. 
Today neurological assessments (most commonly for Alzheimer’s and dementia) are infrequent and subjective, usually requiring a doctor's visit. Early detection of neurological conditions is possible with innovations in diagnosis solutions that use wearable data or sensor data from devices. Companies like [Savonix](https://savonix.com/science/) and [Craniometrix](https://www.craniometrix.com/) have designed a series of mobile tasks to test for symptoms of dementia, and companies like [Winterlight Labs](https://winterlightlabs.com/) detect cognitive impairment solely with speech analysis. These digital tests can monitor disease progression on a regular basis for those predisposed to Alzheimer’s. Early diagnosis allows a care management team to initiate preventative treatment or make modifications to behavioral factors that can delay or even stop the onset of more severe symptoms. 
For other neurological diseases like migraines, companies such as [Neura Health](https://www.neurahealth.co/) can track episodes and identify certain triggers, and the care team is able to suggest personalized lifestyle changes and medication to minimize migraine attacks. 
<center>![Specialty Care - Neurological companies chart](//images.ctfassets.net/vcjxvx0h1a5n/1tdDjYpYHJ8GojtZKyxBgS/34f61a2309dace50b70e7df869a6e16e/specialty_care-blog-graphics_v2_Neurological.png)</center> 
#### Musculoskeletal (MSK) conditions: virtual-first therapy and optimizing navigation
Our mostly sedentary lifestyle and obesity have given rise to musculoskeletal conditions such as arthritis and back pain. It is one of the largest spend buckets in US healthcare, especially amongst self-funded employers, for whom MSK is typically 17% of healthcare budgets. These conditions can also be managed with medication and physical therapy; if unmanaged, MSK can lead to costly surgeries and procedures and chronic pain. 
A number of highly valued digital health companies are emerging in MSK: companies like [Hinge Health](https://www.hingehealth.com/), [Sword Health](https://swordhealth.com/), and [Omada](https://www.omadahealth.com/) are aiming to use virtual physical therapy and personalized care plans to reduce MSK spend for employers. In order to reduce this spend, virtual MSK platforms must engage patients before they see an MSK specialist which puts them in direct competition with traditional providers. [Icon Health](https://iconhealthco.com/) has taken the approach of using outcome data, cost data, and expert clinical knowledge to better navigate employees through their unique MSK journey by directing them to the most appropriate provider (in-person or virtual). 
Most of the solutions in the MSK market today are sold to employers and are focused on reducing the need for surgery. However, there are far fewer solutions working to empower people to receive the best care and surgical outcomes possible when surgery is the correct approach. It will be interesting to see if Medicare or Medicaid solutions emerge to serve different population groups. 
<center>![Specialty Care - MSK companies chart](//images.ctfassets.net/vcjxvx0h1a5n/2GQnUszV54zxL43DD6GngD/0e593e07a0ae56559d8d355daca4a49f/specialty_care-blog-graphics_v2_MSK.png)</center> 
## What success in digital care innovation looks like
Successful chronic care solutions often work hand in hand with in-person primary care and specialty doctors, resulting in continuous disease management support for the patient. One of the reasons we invested in Form Health and Agora Health is because they work in collaboration with primary doctors and gastroenterologists respectively, enabling them to better take care of their patients. That they’re leveraging digital solutions to improve patient care further drives efficiencies. It is important that these virtual efficiencies do not come at the expense of holistic patient care, which is why we are supportive of care models that work in conjunction with in-person care teams. 
If digital care companies can prove this return on investment and become reimbursable through payers, they can expand their acquisition channels and customer base. Reimbursement is especially critical for chronic care where a cash pay/out-of-pocket only model becomes cost-prohibitive for patients. Credibly proving ROI is a critical but challenging key to success, and, of course, much of this reimbursement is beholden to the new CMS codes. 
After an incredibly difficult three years, our nation’s healthcare challenges are only getting worse. Ultimately success looks like improved health for more Americans, and the cost-effective way to achieve that is through patient-centered solutions with a greater focus on education and preventive health. Digital care plays an accessible and affordable role in accelerating early detection, improving habits and lifestyle changes, and ensuring medication management and therapy. We are excited to watch and learn as digital health solutions mature and prove the ROI of virtual solutions. 
We at M13 continue to spend more time and deploy capital into digital health companies. If you are building, investing, writing about, or just curious about the space, we hope you’ll join us on the journey. 
## How to get in touch
We at M13 continue to spend more time and deploy capital into digital health companies. If you are building, investing, writing about, or just curious about the specialty care space, we hope you’ll join us on the journey. 
Contact Morgan at [morgan@m13.co](mailto:morgan@m13.co), and follow her on Twitter at [@morgan_blumberg](https://twitter.com/morgan_blumberg?s=20&t=SGfxqviPsdLuWJWQrG9rdg)

Digital solutions are seizing the opportunity to lower costs and improve outcomes in some of the most challenging and common underlying chronic conditions. 

Specialty Care header

Investing in the Future of Health: Digital Health for Specialty Care

M13’s analysis of healthcare’s integrated digital solutions that are reaching greater efficiencies, lowering costs, and improving patient outcomes in chronic conditions.

Specialty Care thumbnail

The future of Health: Digital Health Specialty Solutions | M13

carter_reum-083022.png

Carter co-founded M13 in 2016 with his brother Courtney. The duo co-founded and sold VEEV, the spirits brand, and co-authored the bestseller “Shortcut Your Startup.” A former Goldman Sachs investment banker, Carter is a LACMA board member.

Carter Reum

Co-founder & Partner

Carter co-founded M13 in 2016 with his brother Courtney. The duo co-founded and sold VEEV, the spirits brand, and co-authored the bestseller “Shortcut Your Startup.” A former...

M13SharePeople-CarterReum

Carter Reum | M13

We are thrilled to announce that M13 is leading [Allocate](https://allocate.co/)’s $15.3M Series A alongside Bedrock and SignalFire, with participation from Intera Capital, Tusk Venture Partners, Urban Innovation Fund, Fika Ventures, Anthemis, Basis Set Ventures, and Broadhaven. 
Allocate is a digital investment platform that provides investors with efficient ways to discover and invest in high quality venture capital funds, while also providing fund managers with a streamlined way to access the fragmented private wealth market. 
## Disrupting the Trillion Dollar Wealth Management Industry
At M13, we look for opportunities where technology can expand access and disrupt large asset classes. We believe the alternative investment market, especially the venture capital market, remains a sector ripe for innovation. While demand for venture products has grown, the most attractive investment opportunities are still primarily reserved for large institutional investors. The majority of the estimated 8,000-11,000 global family offices and nearly 20 million accredited investors are often locked out of the most promising emerging and established strategies due to high minimums, and difficulty of diligence and discovery. 
Allocate has a two-sided value proposition that matches demand with rising supply while also helping GPs alleviate administrative growing pains. The investment dollars flowing into venture capital have increased dramatically over the last ten years, and we believe there will be continued demand from investment advisors, family offices and accredited investors for access to these returns. 
<center> <h3>Venture Funding Tops $100B in 2021</h3> 
![Allocate announcement asset: Venture Funding Tops $100B in 2021](//images.ctfassets.net/vcjxvx0h1a5n/77qxnsFk735gyDkZG9Jj3X/130700bf9c62f3057becafe0308b51c5/Screen_Shot_2022-05-02_at_4.47.07_PM.png) </center>
<center>*Source: [Pitchbook](https://pitchbook.com/news/articles/us-vs-raises-13b-first-week-2022)*</center> 
## How Allocate Works
The company’s platform works by automating product discovery, KYC and AML, subscription documents, capital calls, and investment management. As the platform aggregates investor demand into Allocate feeder vehicles, investors are able to invest in top opportunities at low minimums, enabling them to build diversified and responsible portfolios. Allocate also enables fund managers to efficiently access the $80T high-net worth market without the hassle of managing smaller checks or taking endless meetings. 
Allocate’s clients to date have included wealth advisory firms, small institutions, and family offices. Allocate’s platform is specifically designed for wealth advisors to easily implement private technology-focused products through a full end to end experience that spans investment discovery, deal execution, and ongoing management. 
Since launching the platform only six months ago, Allocate has onboarded more than 200 family offices and wealth advisory firms, and they have allocated over $125M to products listed on the Allocate platform. Allocate has more than 600 investors on its waitlist, which is now moving out of beta and actively onboarding clients. 
To Samir, Hana, and the entire Allocate team: thank you for partnering with us, and we are excited to be on this journey together. 
<center> <h3>Welcome to the M13 family!</h3> </center>

Allocate’s digital platform makes it easy for wealth advisors and family offices to access and track investments into top venture funds.

Allocate Header Artwork

Introducing Allocate: Expanding Access to Venture Capital Investing 

M13 led the $15.3M Series A for Allocate, a digital platform for wealth advisors and family offices to access and track investments into top venture funds.

Allocate Thumbnail Artwork

Introducing Allocate: Expanding Access to VC Investing | M13

We are thrilled to announce that M13 is leading [Canvas Medical](https://www.canvasmedical.com/)’s $24M Series B alongside previous investors including Inspired Capital, IA Ventures, and Upfront Ventures. In addition to this funding, Canvas Medical has achieved ONC certification, which allows Canvas customers to be fully reimbursed in value-based models with Medicare and Medicaid. 
Canvas provides a full-stack ambulatory EMR and digital health developer platform, enabling startups and established healthcare providers alike to launch new patient experiences and business models faster. Canvas is built for two key stakeholders: developers and care teams. A better developer experience enables a modern and intuitive user experience for care teams. This functionality – coupled with Canvas’ narrative charting approach – reduces administrative burden and drives better patient outcomes. 
## Our investment in Canvas is predicated on a few simple principles:
<DotBullet text="Regulatory changes and consumer preferences post the pandemic will spur new digital care models from both new and established healthcare providers. These models require better software that allows customization tailored to specific populations." />
<DotBullet text="This software will be built by an influx of developers entering the healthcare sector who will work closely alongside clinicians. Both developers and clinicians prefer a modern EMR that facilitates more time spent on patient care, and Canvas is the only EMR that comes close to enabling developers to build their software around care delivery. Canvas will become a driving force behind attracting and retaining top talent across the industry." />
<DotBullet text="Value Based Care (VBC) reimbursement models, especially ones focused on serving medicare and medicaid populations, will rely on solutions like Canvas to build complex rules around patient care." />
## Healthcare innovation requires a modern EMR system
We are coming off a record breaking year of tech-enabled healthcare funding to support innovative and complex care models. 2021 was the largest healthcare fundraising year ever, partially due to the pandemic bringing the need for digital care delivery to the forefront. 
<center>![US Healthcare Venture Capital Fundraising (2011-2021)](//images.ctfassets.net/vcjxvx0h1a5n/3Qy8II4GbGr9uh1SE5t705/14a37166a7333cf563fbb91bd03a6a38/silicon-valley-bank-healthcare-investments-and-exits-report_us_healthcare_vc_fundraising_chart-01.png)</center>
<center>*Source: [Silicon Valley Bank](https://www.svb.com/globalassets/library/managedassets/pdfs/silicon-valley-bank-healthcare-investments-and-exits-report.pdf)*</center> 
With new healthtech entrants coming to market daily and established players committed to innovation, we believe these new healthcare companies require a modern platform partner to build better care. 
Healthcare delivery by nature has to be highly personalized and a wide variety of care models exist, each with a focus on a variety of conditions, patients, care providers, reimbursement methods, ect. A product with a static feature set is unscalable and stands in the way of care model innovation, retention of clinicians and attracting developer talent. Canvas is building tools and building blocks for developers to customize and configure their platform to serve each bespoke care model. That is why we believe Canvas is setting the foundation of future healthcare infrastructure. 
## Purpose built for clinicians and developers 
### Developers love building with Canvas
As investors, we have observed software developers entering the healthcare industry which lacks a modern infrastructure on which to innovate. In an increasingly competitive hiring market, we believe that companies building on Canvas will have a recruiting and retention advantage. 
Developers can leverage the Canvas console, APIs and SDKs to build unique care workflows and clinical decision support for the care team. For example, a mental health company might encode customized care journeys in the following ways:
<DotBullet text="If a patient answers that they feel depressed on an intake questionnaire then prompt a mental health diagnosis assessment."/>
<DotBullet text="If a particular diagnosis is confirmed, a customized medication protocol is prompted. Ability to program cost stewardship for high cost intervention."/>
<DotBullet text="If this diagnosis requires additional members of the care team to engage (i.e. therapists, mental health coaches, ect.), then automatically delegate tasks to defined teams."/> 
<style>
 td {
 align: center;
}
</style> 
<div class="container-fluid">
 <div class="row">
 <div class="col-sm-6">
 <td><img src="//images.ctfassets.net/vcjxvx0h1a5n/3FoNzQ6Yb7fXaQzdjzKlwP/360c2e0d35d53c11e7de821eac70d043/canvasmedical-announcement-tweet-chris_hogg.png" alt="Twitter thread from Chris Hogg, CEO of Marley Medical" style="width:100%";></td></div>
 <div class="col-sm-6">
 <td><img src="//images.ctfassets.net/vcjxvx0h1a5n/2sFLL64T9rTkZRARgK7vmS/7d14e8c0c8a37fb60efbbb46c026ffde/canvasmedical-announcement-tweet-jack_stoddard.png" alt="Twitter thread from Jack Stoddard, CEO of Patina" style="width:100%";></td></div>
 </div>
 </div>
<center>*Marley Medical CEO [Chris Hogg](https://twitter.com/cwhogg?s=20&t=awJttKkt0mINB3YjaXLFfg) (left) and Patina CEO [Jack Stoddard](https://twitter.com/jstoddard1?s=20&t=awJttKkt0mINB3YjaXLFfg) (right) praise their partnerships with Canvas Medical via Twitter*</center> 
### Reducing clinicians’ administrative burden
Clinicians are not shy about their frustration with the archaic and non-intuitive existing EMR options. Canvas’s platform is bringing user-centric workflow development to the medical field, which has long been plagued by software that was not built with physicians in mind. For care teams, that means no switching screens, no searching through dozens of tabs and no scrolling through drop-down menus. 
Canvas has revolutionized documentation with its Narrative Charting approach, **which is 3x faster with 80% fewer clicks than traditional EMRs** while reducing duplicate workflow and collecting structured data. The Canvas system is purpose-built to reduce a clinician’s cognitive burden and enables them to spend more time on patient care. 
## Enabling the rise of value based care models
Although prior to the pandemic less than 20% of Medicare spending was in VBC contracts, [CMS](https://www.medicaleconomics.com/view/value-based-care-after-covid-19-what-healthcare-leaders-need-to-know) has announced it wants to move 100% of Medicare providers into two-sided risk arrangements by 2025. In addition, CMS wants 50% of Medicaid and commercial contracts in VBC models by 2025. Canvas customers can now be fully reimbursed in federal value-based payment models and are therefore well-positioned to serve risk bearing models. 
Value based care models require individualized treatment approaches and protocols for each patient subpopulation. Canvas’s suite of products and their ability to customize workflows and interfaces, allows them to embrace the complexity of value based care delivery and facilitate cost savings. 
Andrew Hines, Founder and CEO of Canvas Medical, saw first hand his wife’s struggle with EMR systems as a nurse practitioner and was inspired to build a better solution. He has both the engineering background and experience working with healthcare technology to transform the massive $[30B+](https://www.globenewswire.com/news-release/2021/11/25/2341206/0/en/Electronic-Health-Records-Market-to-Hit-USD-31-5-Bn-by-2030.html) EMR market. 
To Andrew, and the entire Canvas team: thank you for partnering with us, and we are excited to be on this journey together. 
<center><h3>Welcome to the M13 family!</h3></center>

Canvas Medical is reimagining the electronic medical record (EMR) system for the future of healthcare with its digital health developer platform. Canvas enables startups and established healthcare providers alike to launch new patient experiences and business models faster.

Canvas Medical logo (left) next to illustration of Canvas Medical platform UI and backend coding (right)

Canvas Medical header 

Investing in Canvas Medical: Reimagining the EMR for the future of healthcare 

M13 led Canvas Medical’s $24M Series B. Its EMR, digital health developer platform, and ONC certification help healthcare providers launch better patient care models faster. 

Morgan Blumberg

Recently Published

How Gen Z is Driving the Future of Work, Commerce and Living

Investing in the Future of Health: Digital Health for Specialty Care

Introducing Allocate: Expanding Access to Venture Capital Investing

Investing in Canvas Medical: Reimagining the EMR for the future of healthcare

Join our community